Palatin Technologies Files 8-K/A Amendment
Ticker: PTN · Form: 8-K/A · Filed: Aug 11, 2025 · CIK: 911216
| Field | Detail |
|---|---|
| Company | Palatin Technologies Inc (PTN) |
| Form Type | 8-K/A |
| Filed Date | Aug 11, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, disclosure
TL;DR
Palatin Tech filed an amendment to an earlier disclosure. Details to follow.
AI Summary
Palatin Technologies, Inc. filed an amendment (8-K/A) on August 11, 2025, to a previous report dated August 6, 2025. The amendment pertains to a Regulation FD Disclosure. The company, incorporated in Delaware with its principal executive offices in Monmouth Junction, NJ, is involved in the pharmaceutical preparations industry.
Why It Matters
This filing is an amendment to a previous report, indicating a correction or addition to information previously disclosed by Palatin Technologies, Inc. regarding a Regulation FD Disclosure.
Risk Assessment
Risk Level: low — The filing is an amendment to a previous report and does not appear to introduce new material financial or operational information.
Key Players & Entities
- Palatin Technologies, Inc. (company) — Registrant
- August 6, 2025 (date) — Earliest event reported date
- August 11, 2025 (date) — Filing date
- Monmouth Junction, NJ (location) — Principal executive offices
- Regulation FD Disclosure (disclosure) — Item information
FAQ
What is the purpose of this 8-K/A filing?
This filing is an amendment (Amendment No. 1) to a previously filed Current Report on Form 8-K, specifically concerning a Regulation FD Disclosure.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is August 6, 2025.
When was this amendment filed with the SEC?
This amendment was filed as of August 11, 2025.
What is the principal executive office address for Palatin Technologies, Inc.?
The principal executive offices are located at 11 Deer Park Drive, Suite 204, Monmouth Junction, NJ 08512.
What is the company's standard industrial classification?
The company's Standard Industrial Classification is Pharmaceutical Preparations [2834].
Filing Stats: 919 words · 4 min read · ~3 pages · Grade level 12.9 · Accepted 2025-08-11 09:27:21
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share PTN1 NYSE American Indi
Filing Documents
- ptn_8ka.htm (8-K/A) — 28KB
- 0001654954-25-009330.txt ( ) — 145KB
- ptn-20250806.xsd (EX-101.SCH) — 5KB
- ptn-20250806_lab.xml (EX-101.LAB) — 15KB
- ptn-20250806_cal.xml (EX-101.CAL) — 1KB
- ptn-20250806_pre.xml (EX-101.PRE) — 9KB
- ptn-20250806_def.xml (EX-101.DEF) — 2KB
- ptn_8ka_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. The Reverse Stock Split is expected to become effective after market on August 11, 2025 with the Company's Common Stock to begin trading on the OCTQB Market of the OTC Markets Group on a split-adjusted basis at market open on August 12, 2025. The revised timing of the Reverse Stock Split is due to delayed approval from the Financial Industry Regulatory Authority, which we expect after market on August 11, 2025.
Forward-Looking Statements
Forward-Looking Statements This Current Report includes forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as "will" and "expected", or the negative of such terms, or other comparable terminology, and include statements about the Reverse Stock Split and the impacts, if any, on the Company's Common Stock. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, which could cause actual results to differ materially from the forward-looking statements contained herein due to many factors. These forward-looking statements and such risks, uncertainties and other factors speak only as of the date of this Current Report, and the Company expressly disclaims any obligation or undertaking to update or revise and forward-looking statement contained herein, or to reflect any change in the Company's expectations with regard thereto or any other change in events, conditions, or circumstances on which any such statement is based, except to the extent otherwise required by applicable law. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 11, 2025 PALATIN TECHNOLOGIES, INC. /s/ Stephen T. Wills Stephen T. Wills, CPA, MST Executive Vice President, Chief Financial Officer and Chief Operating Officer 3